Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
about
Spinal interleukin-10 therapy to treat peripheral neuropathic painCurrent progress in gene delivery technology based on chemical methods and nano-carriersMolecular aspects of microparticle phagocytosis by dendritic cells.Enhancement of vaccine potency through improved delivery.Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administrationNonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.Drug releasing systems in cardiovascular tissue engineering.The therapeutic potential of interleukin-10 in neuroimmune diseases.Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells.Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain.Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins.Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.Characterization of particles fabricated with poly(D, L-lactic-co-glycolic acid) and an ornithine-histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cells.
P2860
Q26861391-E97272DD-2254-4532-898B-4A213E8F24D0Q28659480-CE04EFA7-D8C1-44A6-8039-205DB52C5879Q33259552-0EE71D9C-3E55-438A-98ED-DB7794111390Q35842648-D6B4B6F6-C82D-4C36-865F-98751A40F87EQ36642679-B44FCD10-42FE-404D-9663-B0289824D49EQ36752048-FD9AD0B1-83B4-4E61-9133-DF056AEF9A38Q37259608-E9962EA3-47F5-469B-A074-3E708361E068Q37451635-02E0BC14-C0A3-49DA-85FD-9098F78B28A9Q37485007-EB3D113D-4271-42A5-B3EF-5DCA6B9D21D6Q41835210-9D68532B-B204-4F8B-9EF9-AA173279BE1CQ42095035-CEC36234-DF2E-4DDA-9814-AC01FE22C83AQ46860089-D2EB7D12-447A-4EF3-B03B-C433D1DDE9C9Q47859509-277208EA-864C-4BA9-BA5F-D88947EE3B5BQ53574381-75461221-DDD6-4036-8EF0-7D138885484A
P2860
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@ast
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@en
type
label
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@ast
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@en
prefLabel
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@ast
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@en
P2860
P356
P1476
Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors.
@en
P2093
Mary Lynne Hedley
P2860
P304
P356
10.1517/14712598.3.6.903
P407
P577
2003-09-01T00:00:00Z